Generally, the ML of non-irradiated crystals decreases with increasing temperature of crystals.
After a 5 h incubation period in the light (pulse), nubbins were transferred to new beakers filled with 200 ml of non-enriched FSW (chase).
The optimal conditions were obtained at molar ratio of 1 2 of furfuryl alcohol to acyl donor, temperature 50 °C with catalyst loading of 30 mg in 3 mL of non-aqueous media toluene.
Weight loss tests were conducted under total immersion in 50 ml of non-deaerated HCl solutions without and with three inhibitors tested.
Selective angiography of the PV was performed with about 40 ml of non-ionic contrast (Ultravist 370, Bayer, Berlin, Germany), in posterior-anterior and left anterior oblique 60° projections.
Before the start of the gradual-salinity-decrease experiment, 24 experimental cups (radius 60 mm, height 147 mm) were prepared, which contained 800 mL of non-diluted, 0.2-μm filtered seawater.
Then volumetric CT acquisition of the abdomen and pelvis during a single breath-hold is performed during intravenous injection of 110 130 ml of non-ionic iodinated contrast medium (such as 350 mgI/ml iomeprol or 370 mgI/ml iopromide) using an automated power injection at a 2.5 ml/s flow rate, with a 75-s scan delay.
Unless contraindicated by history of allergy or impaired renal function, administration of 110 to 130 ml of non-ionic low- or iso-osmolar iodinated contrast medium (CM) such as 350 mgI/mL iomeprol, 320 mgI/ml iodixanol, or 370 mgI/mL iopromide is generally beneficial [4, 6].
A total volume of 80 100 mL of non-ionic contrast medium was injected at a rate of 4.0 4.5 mL/s through an antecubital vein, with 18-s scan delays or the use of Smart Prep at the pulmonary artery.
